NCT05853575 2026-03-27Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Mirati Therapeutics Inc.Phase 2 Active not recruiting200 enrolled
NCT06764771 2025-12-17A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant TumorsBristol-Myers SquibbPhase 1 Active not recruiting437 enrolled
NCT04685135 2025-01-22KRYSTAL-12Mirati Therapeutics Inc.Phase 3 Active not recruiting453 enrolled 20 charts